EMIS has released the TPQH3411 passive harmonic filter for three-phase power systems. The filter is designed to maintain ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Abstract: Better fault-tolerant operation performance of dual three-phase permanent magnet synchronous motor (DTPMSM) has always been pursued by both academia and industry. Torque output capability, ...

Palvella’s QTORIN rapamycin is its main value driver. This candidate is in Phase 3 trials for mLM. Management anticipates its top-line data by Q1 2026, with a potential NDA planned by 2H2026. If ...

Abstract: A nonlinear sliding mode control (SMC) strategy is proposed in this paper for a three-phase, single-stage, grid-tied photovoltaic (PV) system. The controlled system consists of a ...

The 16-week DELTA TEEN phase 3 clinical trial (N=98) assessed the efficacy and safety of delgocitinib cream in adolescents, aged 12-17, with moderate to severe CHE for whom topical corticosteroids are ...

The Andhra Pradesh State Council of Higher Education (APSCHE) will announce the final phase seat allotment result for AP EAMCET 2025 today, 18 September. Candidates who registered for the third and ...

BENGALURU: The special cabinet meeting chaired by Chief Minister Siddaramaiah in Bengaluru on Tuesday decided to implement the ambitious Upper Krishna Project (UKP) Phase-3. The project requires 1.33 ...

Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf, multimodal viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help ...

Cagrilintide was well-tolerated, with the most common side effects being gastrointestinal, including nausea, vomiting, diarrhoea and constipation. These were mainly temporary and mild to moderate.

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance ...